Beigene Ltd (NASDAQ:BGNE)
| 178.00 Delayed Data As of Jun 24 |  +21.80 / +13.96%Today’s Change | 118.18 Today|||52-Week Range 426.56 | -34.30% Year-to-Date |
Latest BGNE News | Press Releases
| Biotech Stock Roundup: MRNA's Jab Update, ACER Down on Regulatory News & More Jun 22 / Zacks.com - Paid Partner Content | Why Shares of BeiGene Popped Today Jun 21 / MotleyFool.com - Paid Partner Content |
| BeiGene, Ltd. (BGNE) Soars 15.5%: Is Further Upside Left in the Stock? Jun 22 / Zacks.com - Paid Partner Content | AbCellera Biologics Inc. (ABCL) Stock Jumps 9.3%: Will It Continue to Soar? Jun 20 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 156.20 |
| Today’s open | 169.26 |
| Day’s range | 166.34 - 181.36 |
| Volume | 24,346 |
| Average volume (3 months) | 330,854 |
| Market cap | $18.4B |
Data as of 4:01pm ET, 06/24/2022
Growth & Valuation
| Earnings growth (last year) | +20.38% |
| Earnings growth (this year) | +17.04% |
| Earnings growth (next 5 years) | -40.95% |
| Revenue growth (last year) | +280.83% |
| P/E ratio | NM |
| Price/Sales | 21.37 |
| Price/Book | 2.93 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TEVATeva Pharmaceutical | +0.08 | +0.98% |
| BBIOBridgeBio Pharma Inc | +0.15 | +1.65% |
| ---- | ||
| IMMBImmunotech Laborator... | 0.00 | 0.00% |
Data as of 4:01pm ET, 06/24/2022
Financials
| Next reporting date | August 5, 2022 |
| EPS forecast (this quarter) | -$3.91 |
| Annual revenue (last year) | $1.2B |
| Annual profit (last year) | -$1.4B |
| Net profit margin | -120.15% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
